Nisa Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.8K | Buy |
267
+26
| +11% | +$7.87K | ﹤0.01% | 1461 |
|
|
2025
Q1 | $79.8K | Buy |
241
+1
| +0.4% | +$331 | ﹤0.01% | 1457 |
|
|
2024
Q4 | $74.1K | Buy |
240
+29
| +14% | +$8.95K | ﹤0.01% | 1557 |
|
|
2024
Q3 | $44.8K | Buy |
211
+68
| +48% | +$14.4K | ﹤0.01% | 1675 |
|
|
2024
Q2 | $40.1K | Buy |
143
+14
| +11% | +$3.92K | ﹤0.01% | 1729 |
|
|
2024
Q1 | $34.4K | Buy |
129
+13
| +11% | +$3.47K | ﹤0.01% | 1742 |
|
|
2023
Q4 | $26.8K | Sell |
116
-90
| -44% | -$20.8K | ﹤0.01% | 1785 |
|
|
2023
Q3 | $30.1K | Buy |
206
+90
| +78% | +$13.1K | ﹤0.01% | 1880 |
|
|
2023
Q2 | $26.8K | Sell |
116
-120
| -51% | -$27.7K | ﹤0.01% | 1980 |
|
|
2023
Q1 | $57K | Buy |
236
+140
| +146% | +$33.8K | ﹤0.01% | 1673 |
|
|
2022
Q4 | $28K | Hold |
96
| – | – | ﹤0.01% | 1954 |
|
|
2022
Q3 | $7K | Sell |
96
-117
| -55% | -$8.53K | ﹤0.01% | 2246 |
|
|
2022
Q2 | $15K | Sell |
213
-115
| -35% | -$8.1K | ﹤0.01% | 2111 |
|
|
2022
Q1 | $32K | Sell |
328
-1,447
| -82% | -$141K | ﹤0.01% | 1955 |
|
|
2021
Q4 | $102K | Sell |
1,775
-1,067
| -38% | -$61.3K | ﹤0.01% | 1512 |
|
|
2021
Q3 | $227 | Sell |
2,842
-3
| -0.1% | – | ﹤0.01% | 1360 |
|
|
2021
Q2 | $277 | Sell |
2,845
-300
| -10% | -$29 | ﹤0.01% | 1307 |
|
|
2021
Q1 | $368 | Hold |
3,145
| – | – | ﹤0.01% | 1260 |
|
|
2020
Q4 | $350K | Buy |
3,145
+728
| +30% | +$81K | ﹤0.01% | 1276 |
|
|
2020
Q3 | $287K | Sell |
2,417
-1,864
| -44% | -$221K | ﹤0.01% | 1206 |
|
|
2020
Q2 | $485K | Buy |
+4,281
| New | +$485K | ﹤0.01% | 1033 |
|